Education
About Us
Working with TipRanks
Follow Us
Leslie Chong Insider Profile
4 Followers
Leslie Chong, Managing Director & Chief Executive Officer at Imugene, holds 2.84M shares in Imugene (Ticker: IUGND), holds 154.90K shares in Chimeric Therapeutics Ltd. (Ticker: AU:CHM).
Leslie Chong Imugene (IUGND)Managing Director & Chief Executive Officer
Imugene (IUGND)
Managing Director & Chief Executive Officer
Ranked #286 out of 102,596 Corporate Insiders
Profitable Transactions
3 out of 7 Profitable Transactions
Average Return
+171.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Leslie Chong holds in companies
Most Profitable Insider Trade
The most profitable trade made by Leslie Chong
Leslie Chong's Trading History
Imugene
Jul 23, 2025
Managing Director & Chief Executive Officer
Uninformative Buy
―
$545.18K
Chimeric Therapeutics Ltd.
Jul 17, 2023
Former
Informative Buy
5.00K
AU$1.70K
List of latest transactions for each holding click on a transaction to see Leslie Chong's performance on stock
You May Also Like
Leslie Chong insider profile FAQ
What is the percentage of profitable transactions made by Leslie Chong?
The percentage of profitable transactions made by Leslie Chong is 43%.
What is the average return per transaction made by Leslie Chong?
The average return per transaction made by Leslie Chong is 171.60%.
What stocks does Leslie Chong hold?
Leslie Chong holds: IUGND, AU:CHM stocks.
What was Leslie Chong’s latest transaction?
Leslie Chong latest transaction was an Uninformative Buy of ―.
What was Leslie Chong's most profitable transaction?
Leslie Chong’s most profitable transaction was an Informative Buy of IUGND stock on March 13, 2020. The return on the trade was 787.00%.
What is Leslie Chong's role in Imugene?
Leslie Chong's role in Imugene is Managing Director & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.